New & Notable
AMA reports low PBM competition, high vertical integration
A 2024 AMA annual report confirms low competition and high vertical integration in PBM markets, urging regulatory action to protect patients and ensure affordability.
Understanding significant mosquito-borne diseases
Common mosquito-borne illnesses, such as Zika virus, West Nile virus, Chikungunya virus, dengue, and malaria, pose public health threats for various communities.
Study uncovers risks of buying semaglutide online
The rise of unregulated online sales of semaglutide poses serious health risks, emphasizing the need for professional guidance and stricter regulation.
Reviewing the CDC 2024-2025 respiratory virus season outlook
The CDC outlines the 2024-2025 respiratory virus season outlook, indicating that combined peak hospitalization rates will be similar to or lower than the previous year.
Insights
Insights is the research division of Xtelligent Healthcare Media. Our work aims to leverage Xtelligent’s diverse readership of healthcare professionals across various sectors of the industry to understand real-world challenges and identify effective solutions.
Access All Reports
Healthcare Strategies: A Podcast
-
A podcast for healthcare professionals seeking solutions to today's and tomorrow's top challenges. Hosted by the editors of Xtelligent Healthcare Media, this podcast series focuses on real-world use cases that are leading to tangible improvements in care quality, outcomes, and cost.
Guests from leading provider, payer, government, and other organizations share their approaches to transforming healthcare in a meaningful and lasting way.
View All Episodes
Latest News
-
FDA clears automatic insulin pump for type 2 diabetes
Automated insulin pumps have previously been available only for type 1 diabetes. However, the FDA recently cleared the Insulet SmartAdjust, the first automatic insulin pump for type 2 diabetes.
-
Eli Lilly's single-dose Zepbound vials expand obesity care
Eli Lilly introduced single-dose vials of Zepbound (tirzepatide) to offer flexible dosing, cost savings and improved obesity care through its Lilly Direct service.
-
FDA approves updated mRNA COVID-19 vaccines
The updated Moderna, Pfizer-BioNTech, Spikevax, and Comirnaty mRNA COVID-19 vaccines, also called the 2024-2025 formulations, should protect against recently circulating strains.
-
Long COVID effects in adolescents, young children vary
NIH-funded research through the RECOVER initiative revealed that long COVID symptoms among pediatric patients varied from sleepiness to headaches, underscoring vaccine importance.
-
FDA clears SleepioRx digital therapeutic for insomnia treatment
Big Health’s SleepioRx received FDA clearance. It is a digital cognitive behavioral therapy solution for chronic insomnia in adults that supports scalable access.
-
Biden administration releases National Heat Strategy
The strategy for 2024–2030 is supposed to promote heat planning, response, and resilience in the wake of extreme heat.
Features
-
Formulating a specialty drug management playbook using expert insights
Using this playbook, healthcare organizations can better navigate the complexities of specialty drug management to optimize care, control costs, and improve patient outcomes.
-
Exploring trends shaping the future of specialty pharmacy
The pharmacy industry is evolving with specialty drugs, requiring advanced management and technology solutions to control costs and improve patient outcomes.
-
Recognizing the growing impact of climate change on infectious diseases
As climate change worsens, its growing impact on global health is becoming alarmingly evident, particularly through the spread of infectious diseases.
-
Exploring AI applications in radiology
Artificial intelligence can play many roles in radiology, including image analysis, interpretation, disease detection, and more.